Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library Smallpox/Monkeypox Vaccine (JYNNEOS™): What You Need to Know

Smallpox/Monkeypox Vaccine (JYNNEOS™): What You Need to Know

Why get vaccinated?

Smallpox/monkeypox vaccine (JYNNEOS™) can help protect against smallpox, monkeypox, and other diseases caused by orthopoxviruses, including vaccinia virus.

Smallpox is a very serious disease caused by variola virus. Some people continue to be at risk of exposure to the virus that causes smallpox, including people who work in emergency preparedness and some laboratory workers. The virus can spread from person to person, causing symptoms including fever and a skin rash. Many people who had smallpox in the past recovered, but about 3 out of every 10 people with the disease died.

Monkeypox is a rare disease with symptoms that are similar to but milder than the symptoms of smallpox. However, monkeypox can cause death. Monkeypox is an emerging infection in Africa and outbreaks of imported cases of monkeypox sometimes happen in other countries, including the United States.

Vaccinia virus can cause disease when people are exposed to infected people (such as exposure to someone who has recently been vaccinated with ACAM2000®, another type of smallpox vaccine) or animals. People who work with vaccinia virus in laboratories can be accidentally exposed to the virus, and if they become infected, they can get sick. However, most vaccinia virus infections resolve on their own without treatment.

Smallpox/monkeypox vaccine (JYNNEOS™)

Smallpox/monkeypox vaccine (JYNNEOS™)

Smallpox/monkeypox vaccine (JYNNEOS™) is made using weakened live vaccinia virus and cannot cause smallpox, monkeypox, or any other infectious disease.

JYNNEOS™ is approved by the Food and Drug Administration (FDA) for prevention of smallpox and monkeypox disease in adults 18 years or older at high risk for smallpox or monkeypox infection.

  • CDC recommends JYNNEOS™ for certain laboratory workers and emergency response team members who might be exposed to the viruses that cause orthopoxvirus infections.
  • CDC recommends consideration of the vaccine for people who administer ACAM2000®, or who care for patients infected with orthopoxviruses.

JYNNEOS™ is usually administered as a series of 2 injections, 4 weeks apart. People who have received smallpox vaccine in the past might only need 1 dose.

Booster doses are recommended every 2 or 10 years if a person remains at continued risk for exposure to smallpox, monkeypox, or other orthopoxviruses. Your health care provider can give you more information.

Talk with your health care provider

Talk with your health care provider

Tell your vaccination provider if the person getting the vaccine:

  • Has had an allergic reaction after a previous dose of smallpox vaccine, or has any severe, life-threatening allergies
  • Has a weakened immune system
  • Is pregnant or thinks they might be pregnant or is breastfeeding

In some cases, your health care provider may decide to postpone routine (pre-exposure) smallpox/monkeypox vaccination with JYNNEOS™ until a future visit.

People with minor illnesses, such as a cold, may be vaccinated. People who are moderately or severely ill should usually wait until they recover before getting a routine (pre-exposure) dose of JYNNEOS™. If you have been recommended to receive JYNNEOS™ due to an exposure to monkeypox virus, you should be vaccinated regardless of concurrent illnesses, pregnancy, breastfeeding, or weakened immune system.

JYNNEOS™ may typically be given without regard to timing of other vaccines. However, certain people at increased risk of a condition called myocarditis (swelling of the heart muscle), including adolescent or young adult males, might consider waiting 4 weeks after JYNNEOS™ vaccination before getting certain COVID-19 vaccines. If you have been recommended to receive JYNNEOS™ due to an exposure to monkeypox virus, you should be vaccinated even if you have recently received a COVID-19 vaccine.

Risks of a vaccine reaction

Risks of a vaccine reaction

  • Redness, soreness, swelling, and itching where the shot is given are the most common things that happen after vaccination with JYNNEOS™.
  • Fatigue (tiredness), headache, and muscle pain can also sometimes happen after vaccination with JYNNEOS™.

People sometimes faint after medical procedures, including vaccination. Tell your provider if you feel dizzy or have vision changes or ringing in the ears.

As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.

You can enroll in v-safe after receiving any dose of Jynneos vaccine by using your smartphone and going to V-safe is a safety monitoring system that lets you share with CDC how you, or your dependent, feel after getting a Jynneos vaccine. For more information visit

What if there is a serious problem?

What if there is a serious problem?

An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.

For other signs that concern you, call your health care provider.

Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself. Visit the VAERS website at or call 1-800-822-7967. VAERS is only for reporting reactions, and VAERS staff members do not give medical advice.

Countermeasures Injury Compensation Program

Countermeasures Injury Compensation Program

The Countermeasures Injury Compensation Program is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines. If you have been injured by smallpox/monkeypox vaccine, you can learn more about this Program by visiting the program’s website at, or calling 1-855-266-2427 (855-266-CICP).

How can I learn more?

How can I learn more?

  • Ask your health care provider.
  • Call your local or state health department.
  • Visit the website of the Food and Drug Administration (FDA) for vaccine package inserts and additional information at
  • Contact the Centers for Disease Control and Prevention (CDC):
    • Call 1-800-232-4636 (1-800-CDC-INFO) or
    • Visit CDC's website at

Vaccine Information Statement

Smallpox/Monkeypox Vaccine


Department of Health and Human Services

Centers for Disease Control and Prevention

Many vaccine information statements are available in Spanish and other languages. See

Hojas de información sobre vacunas están disponibles en español y en muchos otros idiomas. Visite

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna


Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About Cigna Healthcare Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings


Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details